Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GH
#3251
Guardant Health, Inc. - Common Stock
1.3
0
USD
-99.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.03%
Monthly Change
-98.46%
6 month change
-98.80%
Year Change
-98.21%
Previous Close
133.2
2
Open
1.3
0
Low
1.3
0
High
1.3
0
Volume
274
Markets
US Stock Market
Healthcare
GH
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
Total assets
2.27 B
2.2 B
1.61 B
1.79 B
1.49 B
2.01 B
Total liabilities
916.19 M
1.56 B
1.55 B
1.63 B
1.63 B
2.11 B
Total equity
1.3 B
645 M
60.18 M
158.68 M
-139.65 M
-99.31 M
Total liabilities & shareholders' equities
2.27 B
2.2 B
1.61 B
1.79 B
1.49 B
2.01 B
Total debt
806.29 M
1.13 B
1.14 B
1.14 B
1.14 B
1.5 B
Net debt
-988.59 M
162.67 M
101.16 M
-37.27 M
286.47 M
295.9 M
Guardant Health, Inc. - Common Stock
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
News
Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings
Baron Health Care Fund Q1 2026 Portfolio Activity
Guardant Health Just Broke Out On Bullish News For Its Colon Cancer-Detecting Blood Test
Dow Jones Futures Fall After Strong Nvidia Earnings; SpaceX Files For Huge IPO
Guardant Health Leaps On A Major Win In Cancer Detection; Will Shares Break Out?
Guardant Health: Reveal And Shield Driving The Next Growth Phase (NASDAQ:GH)
The Cancer Test That Wall Street Is Betting On
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine (TEM)
Guardant Health, Inc. (GH) Q1 2026 Earnings Call Transcript
Compared to Estimates, Guardant Health (GH) Q1 Earnings: A Look at Key Metrics
Guardant Health (GH) Reports Q1 Loss, Beats Revenue Estimates
Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates